When was NETRI founded?

NETRI was founded in 2018 and raised its 1st funding round 4 years after it was founded.

Where is NETRI located?

NETRI is headquartered in Lyon, France.

Who is the current CEO of NETRI?

Thibault Honegger and Florian Larramendy s of NETRI. Thibault Honegger has also founded 1 company.

How many employees does NETRI have?

As of May 31, 2026, the latest employee count at NETRI is 46.

Is NETRI a funded company?

NETRI is a funded company, having raised a total of $14M across 2 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Mar 03, 2022.

When was the latest funding round of NETRI?

NETRI's latest funding was a $***** Series A round on Feb 04, 2025, with participation from 0 investor.

Where does NETRI rank among its competitors?

NETRI ranks 9th amongst 42 active competitors, of which 22 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Emulate, which secured $493K in Sep, 2025.

Who are the top competitors of NETRI?

NETRI's top competitors include Emulate, CN Bio and Okomera. Among them, Emulate secured the most recent funding round in September, 2025.

NETRI - 2026 Company Profile, Team, Funding, Competitors & Financials

NETRI is a series A company based in Lyon (France), founded in 2018 by Thibault Honegger and Florian Larramendy. It operates as a Developer of microfluidic devices for industrial applications. NETRI has raised $14M in funding. The company has 42 active competitors, including 22 funded and 1 that has exited. Its top competitors include companies like Emulate, CN Bio and Okomera.

Company Details

Developer of microfluidic devices for industrial applications. The company has NeoBento a microfluidic platform that focuses on the development of next-generation 3D brain-on-a-chip models for the treatment of neurological diseases.

Website: netri.com
Social
Email ID: *****@netri.com
Phone Number: +33 **********

Key Metrics

Founded Year

2018

Location

Lyon, France

Stage

Series A

Total Funding

$14M in 2 rounds

Latest Funding Round

Series A, Feb 04, 2025, $*****

Investors

Bpifrance & 5 more

Ranked

9^th among 42 active competitors

Employee Count

46 as on May 31, 2026

Similar Companies

Emulate & 42 more

View NETRI's full profile

NETRI is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Netri CIN: 840248744 , France, Deadpooled	Jun 11, 2018	-	-	-

NETRI has raised a total funding of $14M over 2 rounds. Its first funding round was on Mar 03, 2022. NETRI has 6 institutional investors.

Here is the list of recent funding rounds of NETRI:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 04, 2025	9914526	Series A	6585790	4942858	6557213	1957987
Mar 03, 2022	4690757	Series A	9725654	8598383	3306807	Polygone & 4 more

Access funding benchmarks and valuations. Sign up today!

View details of NETRI's funding rounds and investors

The founders of NETRI are Thibault Honegger and Florian Larramendy. Florian Larramendy and Thibault Honegger are the CEOs of NETRI.

Here are the details of NETRI's key team members:

Thibault Honegger: Co-Founder & CEO of NETRI and founder of 2 other companies, NETRI and Linkio.
Contact Info: 1 email address
Florian Larramendy: CEO - CTO - Co-founder of NETRI.

View details of NETRI's Founder profiles and Board Members

NETRI's employee count trend

NETRI has 46 employees as of May 26. Here is NETRI's employee count trend over the years:

Uncover NETRI's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of NETRI include Emulate, CN Bio and Okomera. Here is the list of Top 10 competitors of NETRI, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Emulate 2013, Boston (United States), Series E	Developer of in vitro models for drug development	$225M	ND Capital, Cedars Sinai & 24 others	59/100
2nd	CN Bio 2009, Cambridge (United Kingdom), Series B	Develops organ-on-a-chip platforms for drug discovery	$71.8M	CITIC, Zray Management & 13 others	58/100
3rd	Okomera 2020, Paris (France), Seed	Developer of a device for in vitro cancer testing using a microfluidic chip	$11.2M	Resonance, Polytechnique Ventures & 4 others	54/100
4th	Hesperos 2015, Orlando (United States), Funding Raised	Developer of organ-on-a-chip solutions for preclinical testing	-	HHS, NCATS	53/100
5th	Nortis 2007, Woodinville (United States), Acquired	Developer of platform for generating small segments of human tissues and organs in microfluidic chips	$10.7M	SeaChange Fund, Vertical Venture Partners ... & 3 others	50/100
6th	Mimetas 2013, Leiden (Netherlands), Series B	Develops microfluidics-based organ-on-a-chip tissue models	$28.9M	Zeeuws Investerings Fonds, Oost NL & 13 others	45/100
7th	Obatala Sciences 2017, New Orleans (United States), Series A	Provider of research enabling products and services to research centers	$3.53M	Ochsner, Ochsner Lafayette General & 9 others	43/100
8th	Cellbox Labs 2020, Riga (Latvia), Seed	Provider of organ-on-chip platform for drug discovery and development	$1.01M	Buildit, ASP Asset Management. & 5 others	43/100
9th	NETRI 2018, Lyon (France), Series A	Developer of microfluidic devices for industrial applications	$14M	Bpifrance, Netangels & 4 others	40/100
10th	Mepsgen 2019, Seoul (South Korea), Series C	Developer of human organ model chips for pharmaceutical development	$29.3M	Korean Development Bank, E&Investment & 6 others	40/100